320 related articles for article (PubMed ID: 31088299)
21. Apoptosis signal-regulating kinase 1 inhibition attenuates human airway smooth muscle growth and migration in chronic obstructive pulmonary disease.
Eapen MS; Kota A; Vindin H; McAlinden KD; Xenaki D; Oliver BG; Deshpande DA; Sohal SS; Sharma P
Clin Sci (Lond); 2018 Jul; 132(14):1615-1627. PubMed ID: 30006481
[TBL] [Abstract][Full Text] [Related]
22. Calpain-1 mediates vascular remodelling and fibrosis via HIF-1α in hypoxia-induced pulmonary hypertension.
Deng H; Tian X; Sun H; Liu H; Lu M; Wang H
J Cell Mol Med; 2022 May; 26(10):2819-2830. PubMed ID: 35365973
[TBL] [Abstract][Full Text] [Related]
23. Reoxygenation Reverses Hypoxic Pulmonary Arterial Remodeling by Inducing Smooth Muscle Cell Apoptosis via Reactive Oxygen Species-Mediated Mitochondrial Dysfunction.
Chen J; Wang YX; Dong MQ; Zhang B; Luo Y; Niu W; Li ZC
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645933
[TBL] [Abstract][Full Text] [Related]
24. Airway smooth muscle NOX4 is upregulated and modulates ROS generation in COPD.
Hollins F; Sutcliffe A; Gomez E; Berair R; Russell R; Szyndralewiez C; Saunders R; Brightling C
Respir Res; 2016 Jul; 17(1):84. PubMed ID: 27435477
[TBL] [Abstract][Full Text] [Related]
25. Chrysin Alleviates Chronic Hypoxia-Induced Pulmonary Hypertension by Reducing Intracellular Calcium Concentration in Pulmonary Arterial Smooth Muscle Cells.
Dong F; Zhang J; Zhu S; Lan T; Yang J; Li L
J Cardiovasc Pharmacol; 2019 Nov; 74(5):426-435. PubMed ID: 31725079
[TBL] [Abstract][Full Text] [Related]
26. Calpain mediates pulmonary vascular remodeling in rodent models of pulmonary hypertension, and its inhibition attenuates pathologic features of disease.
Ma W; Han W; Greer PA; Tuder RM; Toque HA; Wang KK; Caldwell RW; Su Y
J Clin Invest; 2011 Nov; 121(11):4548-66. PubMed ID: 22005303
[TBL] [Abstract][Full Text] [Related]
27. B-type natriuretic peptide inhibits angiotensin II-induced proliferation and migration of pulmonary arterial smooth muscle cells.
Hsu JH; Liou SF; Yang SN; Wu BN; Dai ZK; Chen IJ; Yeh JL; Wu JR
Pediatr Pulmonol; 2014 Aug; 49(8):734-44. PubMed ID: 24167111
[TBL] [Abstract][Full Text] [Related]
28. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
[TBL] [Abstract][Full Text] [Related]
29. Artesunate ameliorates cigarette smoke-induced airway remodelling via PPAR-γ/TGF-β1/Smad2/3 signalling pathway.
Pan K; Lu J; Song Y
Respir Res; 2021 Mar; 22(1):91. PubMed ID: 33757521
[TBL] [Abstract][Full Text] [Related]
30. Isoquercitrin protects against pulmonary hypertension via inhibiting PASMCs proliferation.
Zhang Y; Cui Y; Deng W; Wang H; Qin W; Huang C; Li C; Zhang J; Guo Y; Wu D; Guo H
Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):362-370. PubMed ID: 27873355
[TBL] [Abstract][Full Text] [Related]
31. Chronic toxicity of methamphetamine: Oxidative remodeling of pulmonary arteries.
Liang LY; Wang MM; Liu M; Zhao W; Wang X; Shi L; Zhu MJ; Zhao YL; Liu L; Maurya P; Wang Y
Toxicol In Vitro; 2020 Feb; 62():104668. PubMed ID: 31629073
[TBL] [Abstract][Full Text] [Related]
32. Expression variations of connective tissue growth factor in pulmonary arteries from smokers with and without chronic obstructive pulmonary disease.
Zhou SJ; Li M; Zeng DX; Zhu ZM; Hu XW; Li YH; Wang R; Sun GY
Sci Rep; 2015 Feb; 5():8564. PubMed ID: 25708588
[TBL] [Abstract][Full Text] [Related]
33. Effect of m-calpain in PKCalpha-mediated proliferation of pulmonary artery smooth muscle cells by low dose of ouabain.
Shaikh S; Sarkar J; Pramanik A; Karmakar K; Chakraborti S
Indian J Biochem Biophys; 2013 Oct; 50(5):419-27. PubMed ID: 24772963
[TBL] [Abstract][Full Text] [Related]
34. Involvement of IL-13 in tobacco smoke-induced changes in the structure and function of rat intrapulmonary airways.
Cooper PR; Poll CT; Barnes PJ; Sturton RG
Am J Respir Cell Mol Biol; 2010 Aug; 43(2):220-6. PubMed ID: 19783789
[TBL] [Abstract][Full Text] [Related]
35. Altered Redox Balance in the Development of Chronic Hypoxia-induced Pulmonary Hypertension.
Jernigan NL; Resta TC; Gonzalez Bosc LV
Adv Exp Med Biol; 2017; 967():83-103. PubMed ID: 29047083
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of MicroRNA-214 Contributes to the Development of Vascular Remodeling in Hypoxia-induced Pulmonary Hypertension Via Targeting CCNL2.
Liu H; Tao Y; Chen M; Yu J; Li WJ; Tao L; Li Y; Li F
Sci Rep; 2016 Jul; 6():24661. PubMed ID: 27381447
[TBL] [Abstract][Full Text] [Related]
37. Paeonol regulates hypoxia-induced proliferation of pulmonary artery smooth muscle cells via EKR 1/2 signalling.
Zhang L; Ma C; Gu R; Zhang M; Wang X; Yang L; Liu Y; Zhou Y; He S; Zhu D
Eur J Pharmacol; 2018 Sep; 834():257-265. PubMed ID: 30053410
[TBL] [Abstract][Full Text] [Related]
38. Reactive Oxygen Species in COPD-Related Vascular Remodeling.
Zuo L; Chuang CC; Clark AD; Garrison DE; Kuhlman JL; Sypert DC
Adv Exp Med Biol; 2017; 967():399-411. PubMed ID: 29047102
[TBL] [Abstract][Full Text] [Related]
39. MTOR Suppresses Cigarette Smoke-Induced Epithelial Cell Death and Airway Inflammation in Chronic Obstructive Pulmonary Disease.
Wang Y; Liu J; Zhou JS; Huang HQ; Li ZY; Xu XC; Lai TW; Hu Y; Zhou HB; Chen HP; Ying SM; Li W; Shen HH; Chen ZH
J Immunol; 2018 Apr; 200(8):2571-2580. PubMed ID: 29507104
[TBL] [Abstract][Full Text] [Related]
40. Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension.
Kurosawa R; Satoh K; Kikuchi N; Kikuchi H; Saigusa D; Al-Mamun ME; Siddique MAH; Omura J; Satoh T; Sunamura S; Nogi M; Numano K; Miyata S; Uruno A; Kano K; Matsumoto Y; Doi T; Aoki J; Oshima Y; Yamamoto M; Shimokawa H
Circ Res; 2019 Jul; 125(3):309-327. PubMed ID: 31195886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
